In this study, we showed that in human ERα-positive breast cancer cell lines, TCF21 participated in the ERα-signaling pathway through acting as a negative regulator of ERα, and the interaction between TCF21 and ERα could inhibit the transcriptional activity of ERα. Here, TCF21 is linked to breast cancer.